Pages that link to "Q51792100"

The following pages link to The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects (Q51792100):

Displaying 13 items.

• Population Pharmacokinetics of Lidocaine Administered During and After Cardiac Surgery (Q35464790) (← links)
• Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications (Q36506764) (← links)
• Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery (Q37032255) (← links)
• The effect of intravenous lidocaine on brain activation during non-noxious and acute noxious stimulation of the forepaw: a functional magnetic resonance imaging study in the rat. (Q37189423) (← links)
• Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide (Q38240990) (← links)
• The pharmacokinetics of lignocaine in humans during a computer-controlled infusion (Q39458517) (← links)
• Assessment of liver metabolic function. Clinical implications (Q40648534) (← links)
• Pharmacokinetics of lidocaine delivered from a transmucosal patch in children (Q41364612) (← links)
• Effect of dehydration and hyperosmolal hydration on lignocaine and metabolites disposition in conscious rabbits (Q42096569) (← links)
• Biodegradable poly([D,L]-lactide-co-glycolide) nanofibers for the sustainable delivery of lidocaine into the epidural space after laminectomy (Q47996034) (← links)
• Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures. (Q48257253) (← links)
• The monoethylglycinexylidide test for grading of liver cirrhosis (Q51480746) (← links)
• Dynamics of drug distribution. I. Role of the second and third curve moments (Q52420803) (← links)